Tucidinostat Plus Apatinib for Advanced Osteosarcoma
NCT06125171
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Osteosarcoma
Interventions
DRUG:
Tucidinostat, Apatinib
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology